Fate Therapeutics, Inc.

Fate Therapeutics株式会社別名

銘柄コード

FATE ↗

上場市場

NASDAQ

国

United States of America

従業員（単独）

161

基本情報

BASIC

所在地: 12278 Scripps Summit Drive San Diego, California 92131 United States
社長: Bahram Valamehr
従業員数(単独): 161 人
従業員数(連結)
開始日: 2007-01-01
終了日

§02

サイト

1 DOMAINS

https://fatetherapeutics.com/

§03

事業内容

Cell programming and engineering of induced pluripotent stem cells (iPSCs)Development of clonal master iPSC lines for cell therapy manufacturingOff-the-shelf multiplexed-engineered T cell therapiesOff-the-shelf multiplexed-engineered natural killer (NK) cell therapiesCell therapy product candidate developmentCell therapy developmentClinical drug candidate development for autoimmune diseases and canceriPSC platform-based cell product developmentOff-the-shelf multiplexed-engineered cell product development

§04

ニュース

0 ARTICLES

ニュースはありません。

§09

出典・更新

SOURCES

SOURCEhttps://www.fatetherapeutics.com/about-us/overview/

SOURCEhttps://www.fatetherapeutics.com/

SOURCEhttps://www.fatetherapeutics.com/investors/corporate-governance/

DOMAIN単独ドメイン：あり

UPDATED2026-09-27 03:41 · Model: ggml-org/gpt-oss-20b